RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Clinical Effectiveness for Cangrelor in PCI Not Persuasive
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 5
SP 12
OP 13
DO 10.1177/155989770905003
UL http://mdc.sagepub.com/content/9/5/12.abstract
AB The final results of the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition [CHAMPION] PCI [NCT00305162] and CHAMPION PLATFORM [NCT00385138] trials showed no clinical benefit with cangrelor for the primary composite outcome of death, myocardial infarction, and ischemic-driven revascularization in patients who were undergoing percutaneous coronary intervention.